THOMAS GRAYDEN: Open Payments
NPI 1700942117 · COSTA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $153 · 2025 $186
Food & beverage: $186
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $146 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Almatica Pharma LLC | 1 | $17 |
Products named: COBENFY, INGREZZA, LOREEV XR.
Industry payments across CA — which companies pay providers there.
